Atlas Trials

Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors

Clinical trial NCT01715441 · COMPLETED

Trial details

NCT number
NCT01715441
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors
Start date
2012-09-01
Primary completion
2015-03-01
Enrollment
173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.